Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Univ. of Pittsburgh claims inhibitors of farnesyltransferase/geranylgeranyltransferase

June 27, 1997

Improved dolastatin derivatives prepared by BASF

June 27, 1997

Protein farnesyltransferase inhibitors from Janssen

June 26, 1997

FDA advisory committee withholds recommendation of Ilex Oncology's treatment for AIDS-related NHL

June 26, 1997

Dose of tirapazamine for combination chemotherapy studies selected from phase I data

June 25, 1997

Gemcitabine vs. cisplatin + etoposide for stage III-IV NSCLC

June 24, 1997

Penclomedine: phase I results in patients with solid tumors

June 24, 1997

PBR ligand-melphalan conjugate with promise for brain tumors

June 24, 1997

Medac launches Oncaspar in Germany

June 23, 1997

Taxotere now available in Japan for non-small cell lung and breast cancers

June 23, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
PSB-229 reduces plaque burden in Alzheimer’s models
BioWorld Science
Pyroglutamate-modified amyloid-β (pE3-Aβ) is a highly pathogenic Aβ species that accumulates within amyloid plaques and contributes to aggregation,...